Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer 英文论文文献.docVIP

  • 65
  • 0
  • 约3.63万字
  • 约 9页
  • 2017-05-08 发布于上海
  • 举报

Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer 英文论文文献.doc

Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer 英文论文文献

Yanetal.BMCCancer2010,10:621 /1471-2407/10/621 RESEARCH ARTICLE OpenAccess TopoisomeraseIIalphaexpressionandthebenefit ofadjuvantchemotherapyforpostoperative patientswithnon-smallcelllungcancer ShiYan1,JiaoShun-Chang1*,ChenLi1,LiJie2,LvYa-Li2,WangLing-Xiong3 Abstract Background:Adjuvantchemotherapyhasbeenshowntoimprovesurvivalratesofpostoperativepatientswith non-smallcelllungcancer(NSCLC).BiomarkerscouldhelpselectanappropriatechemotherapyforNSCLCpatients orpredicttheefficacyofchemotherapy.Theobjectiveofthisstudywastoexplorethepossibleprognosticand predictiveroleoftopoisomeraseIIalpha(TopIIa

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档